Evidence map›Paper›PMID 23333561›Full record

ArticleExperimental cell research2013

Hepatocyte growth factor activator inhibitor-2 prevents shedding of matriptase.

Brian R Larsen, Simon D R Steffensen, Nis V L Nielsen, Stine Friis, Sine Godiksen, Jette Bornholdt, Christoffer Soendergaard, Annika W Nonboe, Martin N Andersen, Steen S Poulsen and 6 more

Abstract read
In one paragraph

Article in Experimental cell research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Brian R LarsenDepartment of Cellular and Molecular Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.
Simon D R Steffensen
Nis V L Nielsen
Stine Friis
Sine Godiksen
Jette Bornholdt
Christoffer Soendergaard
Annika W Nonboe
Martin N Andersen
Steen S Poulsen
Roman Szabo
Thomas H Bugge
Chen-Yong Lin
Hanne Skovbjerg
Jan K Jensen
Lotte K Vogel
University of Copenhagen · DKAarhus University · DKNational Institute of Dental and Craniofacial Research · USAmager Hospital · DKUniversity of Maryland, Baltimore · US

Funding

Cell surface serine proteases in development, tissue repair, and malignancyZIADE000699 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI BUGGE, THOMAS H · 2009 to 2025
$34.1M
Serine Proteases In Remodeling Of The Extracellular MatrZ01DE000699 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI BUGGE, THOMAS H · 2000 to 2008
$3.2M
Intramural NIH HHS Z01 DE000699Intramural NIH HHS Z99 DE999999
6 · The paper itself

Abstract

Hepatocyte growth factor activator inhibitor-2 (HAI-2) is an inhibitor of many proteases in vitro, including the membrane-bound serine protease, matriptase. Studies of knock-out mice have shown that HAI-2 is essential for placental development only in mice expressing matriptase, suggesting that HAI-2 is important for regulation of matriptase. Previous studies have shown that recombinant expression of matriptase was unsuccessful unless co-expressed with another HAI, HAI-1. In the present study we show that when human matriptase is recombinantly expressed alone in the canine cell line MDCK, then human matriptase mRNA can be detected and the human matriptase ectodomain is shed to the media, suggesting that matriptase expressed alone is rapidly transported through the secretory pathway and shed. Whereas matriptase expressed together with HAI-1 or HAI-2 accumulates on the plasma membrane where it is activated, as judged by cleavage at Arg614 and increased peptidolytic activity of the cell extracts. Mutagenesis of Kunitz domain 1 but not Kunitz domain 2 abolished this function of HAI-2. HAI-2 seems to carry out its function intracellularly as this is where the vast majority of HAI-2 is located and since HAI-2 could not be detected on the basolateral plasma membrane where matriptase resides. However, minor amounts of HAI-2 not undergoing endocytosis could be detected on the apical plasma membrane. Our results suggest that Kunitz domain 1 of HAI-2 cause matriptase to accumulate in a membrane-bound form on the basolateral plasma membrane.

Indexed as

AnimalsArginineBacterial ProteinsBiomarkersCaco-2 CellsCell MembraneCHO CellsColonic NeoplasmsCricetinaeCulture MediaCytoplasmDogsElectrophoresis, Polyacrylamide GelEndocytosisEndoplasmic ReticulumEnzyme ActivationArginineBacterial ProteinsBiomarkersCulture MediaLuminescent ProteinsMembrane GlycoproteinsProteinase Inhibitory Proteins, SecretoryRecombinant ProteinsRNA, MessengerSerine EndopeptidasesSPINT1 protein, humanSPINT2 protein, humanST14 protein, humanyellow fluorescent protein, Bacteria

Identifiers

PMID23333561
PMCPMC4810019
OpenAlexW2018583592

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.